Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-27

Clinical Trial Update: Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexmedetomidine as premedication in elderly patients with chronic kidney disease undergoing hip fracture surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Baskent University | Conditions: Chronic Renal Failure, Hip Fracture | Phase 3 | Status: COMPLETED